PDF下载 ( 142 KB)
HBV感染的肝硬化和肝细胞癌患者的HDV感染标志的检测
-
摘要: <正> 1988年11月至1989年12月,我们对HBV感染的肝硬化（LC）失代偿患者38例和硬化型肝细胞癌（HCC）患者28例,进行了HBV复制标记和HDV-M同步检测,现将结果报告如下。对象与方法一、对象凡 HBsAg、抗-HBs、HBeAg、抗-HBe及抗-HBc（ELISA）中1项或1项以上阳性者谓HBV感染,具有HBV感染的LC与HCC患者列为检测对象。
-
为使作者了解我刊的编辑出版计划，及时地为我刊惠赐稿件，《临床肝胆病杂志》编委会确定了2022年1-10期“重点号”选题及各期执行主编：
1期 大数据与人工智能赋能肝脏外科数字诊疗新时代····························································刘景丰
2期 儿童肝衰竭的诊断与治疗····························································王建设
3期 肝癌精准诊疗新进展····························································陈 磊
4期 自身免疫性肝病——识机制进展，促临床提升····························································闫惠平
5期 免疫治疗新时代下肝胆肿瘤治疗新进展····························································周 俭
6期 肝硬化门静脉高压的进展与挑战····························································陈金军
7期 非肝硬化性门静脉高压研究进展····························································徐小元
8期 从基础的视角看慢性乙型肝炎治愈及在研新药临床试验评价····························································鲁凤民
9期 肝硬化及其主要合并症的中西医结合治疗····························································刘 平
10期 期异种肝移植的发展与创新····························································窦科峰
为本刊重点号的投稿请注明“***重点号投稿”字样。
对于围绕重点号选题的文章，本刊将择优优先发表。欢迎广大作者踊跃投稿。
《临床肝胆病杂志》编辑部
2022年3月20日
-
下载:
